Elsevier announces major expansion to books program on ScienceDirect

The world's largest scientific, technical and medical full-text database, will add 4,000 titles in 2007 with expanded books program

Amsterdam, 9 November, 2006 - Elsevier today announced the anticipated launch of 4,000 scientific and technical books online in 2007. The program represents a major expansion to the reference works, handbooks and book series already available on ScienceDirect. At launch, the expanded program will comprise high quality selected eBooks titles published from 1995 to the present day. Approximately 50 titles will be added to the eBooks list on ScienceDirect each month following the launch, offering researcher's unparalleled integration and linking between the latest online book and journal information.

"The success of Elsevier’s reference works, handbooks and book series on ScienceDirect proves that librarians and researchers see huge advantages in the availability of electronic book and journal content, fully linked and cross-searchable from one platform," said Joep Verheggen, Director ScienceDirect. "Our customers want ready, easy, electronic access to quality content, to answer demand from their user communities and address their growing concerns about declining shelf space. The addition of these eBooks is a milestone in Elsevier’s delivery of premier scientific literature online."

Elsevier’s award winning book titles including imprints such as Pergamon and Academic Press are widely consulted due to their quality and in-depth coverage of a broad range of scientific disciplines.

Key bestsellers that will be made available online for the first time include: Principles of Tissue Engineering, from Robert Lanza, Robert Langer, and Joseph Vacanti; Handbook of Forensic Psychology, from William O’Donohue, and Eric R. Levensky; and Marine Mammals from Annalisa Berta, and James L. Sumich. The ScienceDirect books program will render these and many other authoritative titles fully searchable and linked not only with referenced book series, handbooks, and reference works but also the world’s largest repository of full-text journal content. This development offers researchers a significantly broader perspective of their field of study, from a single industry leading interface.

For more information, please visit www.info.sciencedirect.com/books

###

About ScienceDirect
Over a quarter of the world’s full text scientific, technical and medical (STM) articles – managed by renowned editors, written by respected authors and read by researchers from around the globe – are available in one place: ScienceDirect.

Elsevier’s extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over seven-and a half million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts. The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2000 journals published by Elsevier and dynamic linking to journals from approximately 350 STM publishers through CrossRef. An expanding program of online major reference works, handbooks and book series in all fields of science seamlessly interlinks with primary research referenced in journal articles. About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact
Gertrude Hoogendoorn
ScienceDirect
+31 20 485-2517
g.hoogendoorn@elsevier.com